Diabetes is the fastest growing chronic condition in Australia, with one person diagnosed every five minutes, according to Diabetes Australia. 高清福利片ers are actively searching not only for a cure, but also for ways people can manage and treat their diabetes now.
Here's a quick look at some of our recent breakthroughs:
A new study is investigating whether blindness in diabetes patients can be reversed. The trial, undertaken by the , is testing whether the cholesterol-lowering drug, fenofibrate, could protect retinal tissue, slowing and even reversing early damage to the eye. By tracking changes in the back of the eye through non-invasive imaging, they can test how well the drug is working.
鈥淲e already know fenofibrate slows and reverses vision loss for type 2 diabetes, as well as protects against kidney and nerve damage,鈥 said Professor , the lead researcher in the trial. 鈥淲e are now calling for people around the world to help us find out if this is the case for those with the more severe type 1 diabetes.鈥
.
Monitoring聽blood levels with the prick of a finger could be replaced with just a breath test in a matter of years, thanks to a聽ketone聽monitoring device that will soon be taken from the lab to the clinic for trials.
鈥淭he breath ketone analyser will be a less invasive and far more accurate way for people with diabetes to monitor their health, by measuring blood ketone levels in the breath,鈥 said Professor聽聽from the聽School of聽Electrical and Information Engineering,聽who leads the multidisciplinary research team in collaboration with AusMed Global and the Australian Trade and Investment Commission.
The device measures blood ketone levels in the breath to detect and prevent incidences of ketoacidosis, a life-threatening event that occurs when the body does not cause enough insulin, causing the liver to produce high levels of ketones that damage the surrounding organs.
Professor of Human Nutrition at the Charles Perkins Centre,聽聽has been a leading contributor to several world-first studies that have advanced the Glycemic Index (GI) from scientific theory to practice, with major implications for the treatment and prevention of diabetes.
For patients with type 2 diabetes, Professor Brand-Miller鈥檚 research showed that a low-GI diet improved average blood glucose levels, a key biomarker that predicts complications. Subsequent trials used a low-GI diet for weight loss, concluding that it鈥檚 possible to delay or even dodge type 2 diabetes as a result of significant weight loss.
A meta-analysis conducted earlier this year at the University of Sydney鈥檚聽Institute of Bone and Joint Research聽found that people with diabetes have a 35 percent higher risk of experiencing low back pain, and a 24 percent higher risk of having neck pain compared to those without diabetes.
While no causal link was found between the two - the investigators say the findings could be accounted to the causal relationship between lifestyle (eg. diet, obesity and exercise) to both diabetes and back pain.
鈥淭ype 2 diabetes and low back pain both have a strong relationship with obesity and lack of physical activity, so a logical progression of this research might be to examine these factors in more detail. Our analysis adds to the evidence that weight control and physical activity play fundamental roles in health maintenance,鈥 says Associate Professor聽.
Researchers from the University of Sydney and the聽聽believe that previously-untapped medical records could be used to predict when a person is at risk of developing type 2 diabetes. By analysing more than 4000 hospital admission records from patients with and without type 2 diabetes, the researchers produced a 鈥榗omorbidity network鈥, mapping patient journeys and development of other conditions.
鈥淚t is well known that chronic diseases such as type 2 diabetes do not occur in isolation, and have a shared set of causes common to many other diseases and disorders,鈥 said study lead author Arif Khan, a postdoctoral researcher at the聽Centre for Complex Systems聽in the聽Faculty of Engineering and Information Technologies.
His team found that, over time, the prevalence of comorbidities in the group of diabetic patients was almost double that of the non-diabetic patients, indicating entirely different ways of disease progression. They hope the network can help healthcare providers to proactively identify patients at high risk of developing chronic disease.